The "Protecting Medical Research Funding Act" prevents funds allocated to the National Institutes of Health (NIH) from being deferred or transferred without explicit authorization from a new law.
Timothy Kennedy
Representative
NY-26
The "Protecting Medical Research Funding Act" prevents the Department of Health and Human Services from deferring or transferring funds made available for the National Institutes of Health (NIH) unless explicitly authorized by a new law referencing this act. The Secretary of Health and Human Services must certify compliance with these requirements to specific congressional committees within 30 days of the bill's enactment and annually thereafter.
This proposed legislation, the "Protecting Medical Research Funding Act," sets up a specific rule for money allocated to the National Institutes of Health (NIH). Essentially, it dictates that federal funds designated for the NIH cannot be held back (deferred) or moved elsewhere (transferred) unless a brand-new law is passed that explicitly authorizes such a move and specifically references this Act.
The core idea here is straightforward: money Congress sets aside for NIH medical research should stay dedicated to that purpose. Section 2 of the bill prohibits using standard budget procedures to shift NIH funds to other agencies or delay their spending. Think of it like putting a specific label on the NIH budget jar that says, "For Medical Research Only - Requires Special Permission to Use Elsewhere." This aims to prevent situations where funds approved for research breakthroughs end up plugging budget holes in unrelated areas without explicit, fresh legislative approval.
To ensure this rule is followed, the bill adds an accountability step. The Secretary of Health and Human Services is required to formally confirm to key committees in both the House and Senate that these funding restrictions are being met. This certification must happen within 30 days of the Act becoming law and then repeat every year. It's a mechanism designed to provide consistent congressional oversight, making sure the intended protection for NIH funds remains actively monitored.